An_DT
alternatively_RB
spliced_VBN
isoform_NN
of_IN
the_DT
Spi-B_NN
transcription_NN
factor_NN
._.

Spi-B_NN
is_VBZ
an_DT
Ets_NN
transcription_NN
factor_NN
related_JJ
to_TO
the_DT
oncoprotein_NN
Spi-1_NN
\/_:
PU_NN
.1_NN
and_CC
highly_RB
expressed_VBN
in_IN
B_NN
lymphoid_JJ
cells_NNS
._.

The_DT
Ets_NN
proteins_NNS
share_VBP
a_DT
conserved_VBN
Ets_NN
domain_NN
that_WDT
mediates_VBZ
specific_JJ
DNA_NN
binding_NN
._.

Spi-B_NN
binds_VBZ
DNA_NN
sequences_NNS
containing_VBG
a_DT
core_NN
5_CD
'_``
-_NN
GGAA-3_JJ
'_''
and_CC
activates_VBZ
transcription_NN
through_IN
this_DT
motif_NN
._.

Up_IN
to_TO
date_NN
,_,
the_DT
biological_JJ
function_NN
of_IN
Spi-B_NN
remains_VBZ
unknown_JJ
._.

Here_RB
,_,
we_PRP
describe_VBP
the_DT
characterization_NN
of_IN
an_DT
alternatively_RB
spliced_VBN
variant_NN
of_IN
Spi-B_NN
,_,
named_VBN
deltaSpi-B_NN
,_,
which_WDT
has_VBZ
lost_VBN
the_DT
Ets_NN
domain_NN
._.

In_IN
B_NN
lymphoid_JJ
cells_NNS
,_,
deltaspi-B_NN
and_CC
spi-B_NN
mRNAs_NNS
were_VBD
present_JJ
simultaneously_RB
in_IN
a_DT
ratio_NN
of_IN
around_IN
10_CD
%_NN
._.

DeltaSpi-B_NN
product_NN
was_VBD
not_RB
able_JJ
to_TO
bind_VB
DNA_NN
and_CC
was_VBD
recovered_VBN
in_IN
cytoplasmic_JJ
cellular_JJ
extracts_NNS
._.

We_PRP
raise_VBP
the_DT
hypothesis_NN
that_IN
delta_NN
Spi-B_NN
might_MD
affect_VB
Spi-B_NN
function_NN
by_IN
recruiting_VBG
factors_NNS
involved_VBN
in_IN
Spi-B_NN
activity_NN
._.

